voxelotor
Global Blood Therapeutics
[]
$gbt gbt presents positive new real-world evidence data at eha2022 congress further supporting clinical use of oxbryta (voxelotor) in sickle cell disease 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities